CRP and amyotrophic lateral sclerosis: We compared Raman data to established clinical measures of disease severity, standard clinical analytes known as promising biomarkers of disease activity (C-reactive protein,22 ferritin23 and complement24) and the leading new serum biomarker for ALS (neurofilament-light, NfL25,26).